Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis

Launched by INSTITUT DU CANCER DE MONTPELLIER - VAL D'AURELLE · Jul 17, 2019

Keywords

ClinConnect Summary

This clinical trial is studying a technique called cardiac coherence, which involves breathing exercises aimed at helping patients feel calmer and less anxious before undergoing surgery for peritoneal carcinosis, a condition that affects the lining of the abdomen. The goal is to see if this technique can reduce anxiety levels in patients who are preparing for major surgery related to conditions like colon or stomach cancer.

To participate in the trial, patients need to be over 18 years old and have been diagnosed with peritoneal carcinosis, as well as experience significant anxiety before their surgery. They must also be able to speak French and be hospitalized at the Institute of Cancer in Montpellier the day before their surgery. If eligible, participants will learn and practice the cardiac coherence technique, and researchers will monitor how it affects their anxiety levels. It's important to note that certain individuals, such as those with severe heart conditions or specific psychiatric disorders, will not be able to participate in the trial.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age over 18 years
• • 2. Patients with peritoneal carcinosis awaiting cytoreductive surgery
• • 3. Patients who scored strictly above 3 on the visual analogue anxiety scale and/or the psychological distress scale
• • 4. Patients with sufficient command of the French language
• • 5. Patient affiliated to a French social security system
• • 6. Patient hospitalized at the Institute of cancer of Montpellier the day before his cytoreductive surgery (at T1 = D-1)
• • 7. Signing of informed consent before any specific trial procedure
• Exclusion Criteria:
• • 1. Patients who already have daily practice of cardiac coherence
• • 2. Presence of proven psychiatric disorders (e.g., mental retardation, psychotic disorders, learning disabilities, attention deficit/hyperactivity, bipolar disorder, etc.) other than mood disorders that are reactive to the disease experience, or receiving psychotic treatment that may impair thinking, judgment or discernment
• • 3. Physical or sensory inability to respond to questionnaires
• • 4. Patients who have had a heart transplant or bypass surgery in the Year before surgery
• • 5. Patient with a history of uncontrolled neurological pathology within the last 6 months before inclusion in the trial
• • 6. Patients with a history of psychoactive substance dependence (excluding smoking) in the last 6 months before inclusion in the trial
• • 7. Patients with brain metastases
• • 8. Known natural bradycardia 50 beats per minute
• • 9. Beta-blocker intake in progress
• • 10. Ongoing cardiac arrhythmias
• • 11. Known severe heart failure with ventricular ejection fraction strictly Below 40 %
• • 12. Chronic uncontrolled pain and making it difficult to practice the technique
• • 13. Patient with chronic obstructive pulmonary disease
• • 14. Legal incapacity (patient under guardianship or curatorship)